Division of Pulmonary and Critical Care Medicine, Department of Medicine, University of Washington Medical Center, Seattle, Washington 98195, USA.
Thorax. 2011 Dec;66(12):1106-8. doi: 10.1136/thoraxjnl-2011-200611. Epub 2011 Aug 3.
Continuous quality improvement (CQI) in healthcare can be described as a reiterative approach to improving processes to reduce unexpected variation in health outcomes. CQI represents one model to achieve quality improvement (QI) and has long been recognized as a key to success in the manufacturing industry with companies like Toyota leading the way.
Healthcare, and specifically pulmonary, critical care and sleep medicine represent ideal settings for the application of CQI.
This opinion piece will describe QI and CQI initiatives in the US Cystic fibrosis (CF) population.
QI in CF care in the United States has been ongoing since inception of the US CF Foundation (CFF) in 1955. This effort has included work to improve the quality of clinical care provided at CF centers and work to improve clinical outcomes in CF. More recently, QI methods have been applied to the conduct of clinical research.
The CF community has become a leader in the area of QI and has pointed out the opportunities for others to follow in the area of lung diseases.
医疗保健中的持续质量改进(CQI)可以被描述为一种反复改进流程的方法,旨在减少医疗结果中意外的变化。CQI 代表了一种实现质量改进(QI)的模式,它长期以来一直被认为是制造业成功的关键,丰田等公司在这方面处于领先地位。
医疗保健,特别是肺部、重症监护和睡眠医学,是 CQI 的理想应用场所。
本文将描述美国囊性纤维化(CF)人群中的 QI 和 CQI 计划。
自 1955 年美国 CF 基金会(CFF)成立以来,美国 CF 护理中的 QI 一直在持续进行。这一努力包括改善 CF 中心提供的临床护理质量的工作,以及改善 CF 临床结果的工作。最近,QI 方法已应用于临床研究的开展。
CF 社区已成为 QI 领域的领导者,并指出了其他人在肺部疾病领域可以效仿的机会。